Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Posted Basic Consolidated EPS Of $-0.6684

0

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) annual basic consolidated EPS was $-0.6684 for the period ended 2015-08-31. The basic consolidated EPS was $-0.6684 for the quarter ended 2015-08-31.

EPS from continuing operations

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)’s basic EPS from continuing operations was $-0.6684 for the fiscal year 2015-08-31. For the quarter ended 2015-08-31 it stood at $-0.6684

EPS contribution from parent

From the parent company Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) posted basic EPS of $-0.6684 for the fiscal ended 2015-08-31. For the quarter that ended on 2015-08-31 the figure stood at $-0.6684.

Basic net EPS

The Basic net EPS of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) was $-0.67 for the period ended 2015-08-31. The figure stood at $-0.67 for the quarter that ended 2015-08-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-08-31 stood at $-0.6684. While the figure for the quarter ended 2015-08-31 stood at $-0.6684.

Basic diluted EPS

The diluted EPS from continuing operation of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) stood at $-0.6684 for the fiscal 2015-08-31. The figure for the quarter ended 2015-08-31 stood at $-0.6684

Net diluted EPS

The Net diluted EPS was $-0.67 for the fiscal 2015-08-31. The figure for the quarter ended 2015-08-31 stood at $-0.67.

Diluted EPS from parent

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) diluted EPS from the parent company for the fiscal 2015-08-31 was $-0.6684. The figure for the quarter ended 2015-08-31 was $-0.6684

The net basic EPS was $-0.67 for fiscal 2015-08-31. The figure for the quarter ended 2015-08-31 was $-0.67

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 25 times, 1 visits today)